0001140361-13-046213.txt : 20131213 0001140361-13-046213.hdr.sgml : 20131213 20131213193135 ACCESSION NUMBER: 0001140361-13-046213 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20131211 FILED AS OF DATE: 20131213 DATE AS OF CHANGE: 20131213 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MYLAN INC. CENTRAL INDEX KEY: 0000069499 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 251211621 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1500 CORPORATE DRIVE CITY: CANONSBURG STATE: PA ZIP: 15317 BUSINESS PHONE: 724-514-1800 MAIL ADDRESS: STREET 1: 1500 CORPORATE DRIVE CITY: CANONSBURG STATE: PA ZIP: 15317 FORMER COMPANY: FORMER CONFORMED NAME: MYLAN LABORATORIES INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: FRM CORP DATE OF NAME CHANGE: 19711003 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KORMAN HARRY CENTRAL INDEX KEY: 0001197548 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09114 FILM NUMBER: 131277468 MAIL ADDRESS: STREET 1: MYLAN LABORATORIES INC STREET 2: 1718 NORTHROCK CT CITY: ROCKFORD STATE: IL ZIP: 61103 4 1 doc1.xml FORM 4 X0306 4 2013-12-11 0 0000069499 MYLAN INC. MYL 0001197548 KORMAN HARRY 1500 CORPORATE DRIVE CANONSBURG PA 15317 0 1 0 0 Chief Operating Officer Common Stock 2013-12-11 4 M 0 24898 21.13 A 141293 D Common Stock 2013-12-11 4 S 0 24898 41.7504 D 116395 D Common Stock 2013-12-11 4 M 0 15288 22.66 A 131683 D Common Stock 2013-12-11 4 S 0 15288 41.8372 D 116395 D Common Stock 2013-12-11 4 M 0 9814 23.44 A 126209 D Common Stock 2013-12-11 4 S 0 9814 41.9437 D 116395 D Common Stock 1001 I By 401(k) Plan Stock Option Right to Buy 21.13 2013-12-11 4 M 0 24898 0 D 2020-03-03 Common Stock 24898 4732 D Stock Option Right to Buy 22.66 2013-12-11 4 M 0 15288 0 D 2021-03-02 Common Stock 15288 7644 D Stock Option Right to Buy 23.44 2013-12-11 4 M 0 9814 0 D 2022-02-22 Common Stock 9814 48016 D Represents the weighted average price of the reporting person's disposition of 24,898 shares in transactions ranging from $41.51 to $42.48. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 1, 3, and 4 to this Form 4. Represents the weighted average price of the reporting person's disposition of 15,288 shares in transactions ranging from $41.57 to $42.48. Represents the weighted average price of the reporting person's disposition of 9,814 shares in transactions ranging from $41.70 to $42.48. This option exercise and the related sale of the underlying common stock were executed pursuant to a 10b5-1 trading plan dated November 22, 2013. The options vested in three equal installments on March 3, 2011, 2012, and 2013. Two-thirds of the options vested in equal installments on March 2, 2012 and 2013. The remainder of the options will vest on March 2, 2014. One-third of the options vested on February 22, 2013. The remainder of the options will vest in equal installments on February 22, 2014 and 2015. /s/ Harry Korman 2013-12-13